Furthermore, down-regulation of SNORA65 has been reported in chemo-sensitive ovarian adenocarcinoma compared to chemo-resistant tumours [26], and deregulation of SNORD116-25 in multiple myeloma [16]. This evidence concerns the gene SNORA65 and AL amyloidosis.